Skip to content
Magazine
Advertisements
Issues
Savings Card
Events
News
Artificial Intelligence
Funding
Pharmacies
Medical Devices
Medical Technology
Pharma and Biotech
NGOs
Investments
Mergers and Acquisitions
Hospitals
About Us
Videos
AI Chat Bot
Magazine
Advertisements
Issues
Savings Card
Events
News
Artificial Intelligence
Funding
Pharmacies
Medical Devices
Medical Technology
Pharma and Biotech
NGOs
Investments
Mergers and Acquisitions
Hospitals
About Us
Videos
AI Chat Bot
Search
$
0.00
0
Cart
Pharma and Biotech
Mergers and Acquisitions
,
Pharma and Biotech
Eli Lilly acquires Organovo’s FXR agonist for US $10M upfront
Pharma and Biotech
Takeda expands partnership with BridGene in US $770M deal
Pharma and Biotech
J&J sues Samsung Bioepis over alleged Stelara biosimilar breach
Pharma and Biotech
Pfizer drops Beqvez, ending its gene therapy efforts
Mergers and Acquisitions
,
Pharma and Biotech
Bluebird Bio goes private in US $29M deal with Carlyle, SK Capital
Pharma and Biotech
Roche’s Evrysdi could be used to treat SMA before birth
Pharma and Biotech
NHS approves UCB’s epilepsy drug Fintepla for severe seizures
Pharma and Biotech
Boehringer’s oral HER2 drug awaits FDA decision in third quarter
Pharma and Biotech
NICE reverses decision on BMS’ lymphoma therapy, approves NHS funding
Pharma and Biotech
AstraZeneca expands in China with US $160M FibroGen deal
Pharma and Biotech
Goldman Sachs raises Everest Medicines’ target price amid strong growth prospects
Medical Technology
,
Pharma and Biotech
ABIONYX Pharma’s sepsis project gains recognition under France 2030 plan
